Trials / Conditions / Carcinoma Breast Stage IV

Carcinoma Breast Stage IV

12 registered clinical trials studyying Carcinoma Breast Stage IV.

Status	Trial	Sponsor	Phase
Unknown	Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration NCT06281860	Dr Jean Yannis PERENTES	Phase 1
Active Not Recruiting	A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast C NCT02755272	Fox Chase Cancer Center	Phase 2
Completed	Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer NCT03511781	Tata Medical Center	N/A
Terminated	Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Ca NCT02183805	Sun Yat-sen University	Phase 2
Unknown	Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer NCT02161315	Tianjin Medical University Cancer Institute and Hospital	—
Withdrawn	Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC NCT02140437	Fudan University	Phase 2
Withdrawn	Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. NCT01906112	National Cancer Institute, Thailand	Phase 3
Completed	Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer NCT01631552	Gilead Sciences	Phase 1 / Phase 2
Terminated	BIBW 2992 (Afatinib) and Vinorelbine NCT01531764	University of Magdeburg	Phase 2
Completed	Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer NCT00669565	Peregrine Pharmaceuticals	Phase 2
Completed	PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 NCT00199212	Jules Bordet Institute	Phase 1
Completed	Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer NCT00433095	Ludwig-Maximilians - University of Munich	Phase 2